As per new recommendations of NEGVAC, COVID19 vaccination to be deferred by 3 months after recovery from the illness
If infected with COVID after 1st dose, 2nd dose to be deferred by 3 months after clinical recovery from COVID-19 illness
COVID-19 vaccination recommended for all Lactating Women
No Screening of vaccine recipients by Rapid Antigen Test (RAT) prior to COVID19 vaccination
The National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) has shared fresh recommendations regarding COVID-19 vaccination with the Union Ministry of Health and Family Welfare.
These recommendations have been based on the evolving situation of the COVID-19 pandemic and emerging global scientific evidence & experience.
Union Ministry of Health and Family Welfare has accepted these recommendations, which are as follows, and has communicated these to the States and UTs also:
Deferring the COVID-19 vaccination in the following scenario:
Individuals having lab test proven SARS-2 COVID-19 illness- COVID-19 vaccination to be deferred by 3 months after recovery.
SARS-2 COVID-19 patients who have been given anti-SARS-2 monoclonal antibodies or convalescent plasma: COVID-19 vaccination to be deferred by 3 months from the date of discharge from the hospital.
Individuals who have received at least the 1st dose and got COVID-19 infection before completion of the dosing schedule: the 2nd dose should be deferred by 3 months after clinical recovery from COVID-19 illness.
Persons with any other serious general illness requiring hospitalization or ICU care should also wait for 4-8 weeks before getting the COVID-19 vaccine.
An individual can donate blood after 14 days of either receipt of COVID-19 vaccine or testing RT-PCR negative, if suffering from COVID-19 disease.
COVID-19 vaccination is recommended for all lactating women.
There is no requirement for screening of the vaccine recipients by rapid antigen test (RAT) prior to COVID-19 vaccination.